Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,203 trials

NCT07023666
Recruiting
Early Screening and Treatment of Heart Complication in Sickle Cell Disease
Phase 2 · United States · 2 sites
Registry update: 9 Sept 2026
NCT06876064
Recruiting
National Cohort of Subjects at Risk of Developing Rheumatoid Arthritis
Not applicable · France · 1 site
Registry update: 1 Oct 2026
NCT07424027
Recruiting
Central Vein Sign in Multiple Sclerosis Extension Study
Not applicable · United States · 3 sites
Registry update: 20 Feb 2026
2024-518759-45-00
Recruiting
Evaluation of the efficacy and safety of prolonged-release budesonide in children with primary IgA nephropathy.
Phase 3 · Poland · 8 sites
Registry update: 13 Mar 2026
NCT07354009
Recruiting
Efficacy and Safety of iStent in Reducing Intraocular Pressure in Open-angle Glaucoma
Not applicable · China · 1 site
Registry update: 21 Jan 2026
NCT06559033
Recruiting
Determine the Frequency of Variants in the GBA/PSAP Genes in Patients With MM or MGUS
Not applicable · France · 2 sites
Registry update: 10 Jun 2026
NCT07356778
Recruiting
A Study of Sotatercept for Patients With Eisenmenger Syndrome or Unrepaired Shunt-Associated Pulmonary Arterial Hypertension Resistant to Vasodilator Therapy
Phase 4 · Japan · 10 sites
Registry update: 21 Jan 2026
NCT07097142
Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Phase 3 · Canada, United States · 259 sites
Registry update: 23 Oct 2026
NCT06988488
Recruiting
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma
Phase 1/2 · Canada, China, Germany, Spain, United Kingdom, Greece, Norway, United States · 22 sites
Registry update: 2 Sept 2026
NCT07171658
Recruiting
Breast Cancer-Related Approach for Increasing Cervical Cancer Screening
Not applicable · Switzerland · 1 site
Registry update: 22 Dec 2025
NCT07058389
Recruiting
Synergy Between Physical Activity and Outdoor Green Environments to Reduce the Intensity of Negative Symptoms in Schizophrenia.
Not applicable · France · 1 site
Registry update: 25 Nov 2025
NCT07139418
Recruiting
The Clinical Significance of Examining Metastatic Lymph Nodes in Individual Gastric Mesenteries in the Patients With Gastric Cancer Undergoing Gastrectomy
Not applicable · China · 1 site
Registry update: 11 Mar 2026
NCT04119024
Recruiting
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Phase 1 · United States · 3 sites
Registry update: 17 Mar 2026
NCT06955481
Recruiting
Study to Evaluate the Performance of Navigated TKA With OrthoPilot® pheno4u TKA Level 1
Not applicable · Czechia, Germany · 4 sites
Registry update: 17 Nov 2025
NCT07246863
Recruiting
Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC
Phase 2 · Switzerland, Germany, Spain, Italy, Poland, Romania, United States · 43 sites
Registry update: 26 Oct 2026
NCT07065630
Recruiting
Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer
Phase 2 · United States · 1 site
Registry update: 4 Mar 2026
NCT07116057
Recruiting
MOv19-BBz CAR T Cells in FRa+ Cancers
Phase 1 · United States · 1 site
Registry update: 7 Oct 2026
NCT07070219
Recruiting
A Study of CTD402 in T-ALL/LBL Patients
Phase 1/2 · Australia, United States · 9 sites
Registry update: 19 Aug 2026
NCT06649812
Recruiting
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
Phase 2 · United States · 115 sites
Registry update: 9 Nov 2026
NCT06994338
Recruiting
Tirzepatide for Alcohol Use Disorder
Phase 2 · United States · 1 site
Registry update: 14 Oct 2025

Ordered by registry start date. Freshness and sponsorship never change the order.